A 29-year-old woman with a history of gastric bypass one year before and a family history of diabetes (a history of type 2 diabetes; a diagnosis of type 1 diabetes at 7 years of age).
The patient presented two months before (20 March 2020) with severe asthenia, fever, stiffness and dyspnea.
He then presented anosmia and ageus with anorexia (25th March).
She was admitted to the emergency department and started symptomatic treatment for preexisting infection with COVID-19 and was discharged (glycemia was normal).
Two weeks later, she had no symptoms.
However, one month after his first symptoms of COVID-19 (24 April), he presented acute polyuria-polydipsia.
Diabetes mellitus (12 May) was diagnosed with a glycaemia of g/l (20.5 mmol/l), non-significant ketosis (0.7 mmol/l) and normal bicarbonate value (26 mmol/l).
HbA1c was 1.8% (105 mmol/mol).
His weight was 120 kg before gastric bypass and 65 kg before COVID-19 and 57 kg (BMI 21.5 kg/m2) at the time of diagnosis of diabetes.
Diabetes required insulin immediately, and was treated with a basal bolus regimen.
There were no metabolic comorbidities and the markers were normal (no hypertension, negative C-reactive protein (< 0.6mg/l, hdlc 0.46g/l, Ldlc 0.43g/l, AST, triglycerides 0.42g/l).
The values of lipase and TSH were normal; pancreatic CT was normal.
C-peptide was low with pmol/ml (normal values between 0.37 and 1.47).
Antibodies against pancreatic beta cells were tested, and finally anti-decarboxylase-65 autoantibodies of glutamic acid were positive (GAD-65A, 93 IU/ml, anti-zinc-transporter type) while antibodies were negative for beta
The serology of SARS-CoV-2 was positive, confirming infection by COVID-19.
